article thumbnail

Pharmas and medtechs flex brand protection among Top 100 New Brands for 2023

Clarivate

Biopharma and medtech brands made up a dozen of the Clarivate Top 100 New Brands for 2023, as the life science industries continued to show a muscular approach to protecting their intellectual property. Incyte also notches two mentions, first for the U.S.-based

Pharma 52
article thumbnail

Improve Your Health, Meet in Person

PM360

Biopharma should pay special attention to this. You’re the gatekeeper of all communication on your platform, and participants are unlikely to network with one another independently. By contrast, when patients get together in one location under your guidance, they will likely bond and form friendships and build support networks.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Five IDNs to watch in 2023

Clarivate

healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. In a fiercely competitive U.S. Christopher Silva, Senior Healthcare Research Analyst.

article thumbnail

HCP Engagement & Education

PM360

With an ever- increasing demand for their time and attention, it is more difficult than ever for biopharma representatives to convey their message to the physician audience. In one survey, only 12% of HCPs said they felt biopharma companies are very effective at providing HCP education and training to them.